Skye Bioscience Inc.

SKYE | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.75

-$0.03 (-1.69%)

Sep 22, 2026, 12:47 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $7.82M

Enterprise Value $-2.21M

Beta 2.90

Average Volume 287.81K

Shares Outstanding (Diluted) 4.96M

Shares Change YoY 0.06%

Institutional Ownership 40.65%

Exchange NASDAQ

ISIN US83086J3095

Price Performance

Price Change 1M -18.7%

Price Change 3M -68.2%

Price Change 6M -64.4%

Price Change YTD -74.7%

Price Change 1Y -94.3%

Price Change 3Y -93.5%

Price Change 5Y -99.2%

1M CAGR (ann.) -57.2%

1Y CAGR (ann.) -94.3%

5Y CAGR (ann.) -63.1%

All-Time CAGR -54.5%

Valuation

PE Ratio -0.18

Forward PE N/A

PEG Ratio 0.01

Forward PEG -0.01

PS Ratio N/A

Forward PS N/A

PB Ratio -15.72

P/FCF Ratio -0.20

P/Adj. FCF Ratio 0.00

P/OCF Ratio -0.23

EV/Sales N/A

EV/EBIT 0.04

EV/EBITDA 0.04

EV/FCF 0.06

Earnings Yield -570.8%

FCF Yield -496.3%

Adj. FCF Yield 27554.2%

Financial Health

Net Cash $10.06M

Total Debt $35.7K

Cash & Short-Term Investments $10.06M

Total Assets $11.03M

Current Ratio 0.95

Quick Ratio 0.95

Debt / Equity Ratio -0.07

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt -1,087.25

Interest Coverage -9,439.02

Altman Z-Score -41.42

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -5651.6%

Returns

Return on Assets -457.6%

Return on Equity -329.1%

Return on Invested Capital 11242.3%

Return on Capital Employed 10435.4%

Return on Tangible Assets -457.6%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 63.5%

EPS CAGR 5Y 45.1%

EPS CAGR 10Y 34.4%

FCF CAGR 3Y -0.3%

FCF CAGR 5Y -49.8%

FCF CAGR 10Y -42.2%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 5

EPS Growth Next 3Y -7.9%

Revenue Growth Next 3Y N/A

Earnings Date Nov 8, 2026

EPS Estimate (next Q) -$1.14

EPS Growth Est (next Q) -55.4%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $12

Price Target Upside 574.2%

Cash Flow

Operating Cash Flow $-38.81M

Free Cash Flow $-38.81M

Adj. Free Cash Flow $2.15B

FCF Per Share -$7.82

OCF Per Share -$7.82

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-172.89K

Operating Income $-51.9M

EBITDA $-49.95M

Net Income $-50.49M

EPS (Diluted) -$10.16

Revenue / Employee N/A

Profit / Employee $-25.25M

Employees 2